FR21C1033I1 - DRUG DELIVERY SYSTEM COMPRISING TETRAHYDROXYL ESTROGEN FOR HORMONAL CONTRACEPTION - Google Patents

DRUG DELIVERY SYSTEM COMPRISING TETRAHYDROXYL ESTROGEN FOR HORMONAL CONTRACEPTION

Info

Publication number
FR21C1033I1
FR21C1033I1 FR21C1033C FR21C1033I1 FR 21C1033 I1 FR21C1033 I1 FR 21C1033I1 FR 21C1033 C FR21C1033 C FR 21C1033C FR 21C1033 I1 FR21C1033 I1 FR 21C1033I1
Authority
FR
France
Prior art keywords
tetrahydroxyl
estrogen
delivery system
drug delivery
hormonal contraception
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Estetra SRL
Original Assignee
Estetra SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01201945A external-priority patent/EP1293210B1/en
Application filed by Estetra SRL filed Critical Estetra SRL
Publication of FR21C1033I1 publication Critical patent/FR21C1033I1/en
Application granted granted Critical
Publication of FR21C1033I2 publication Critical patent/FR21C1033I2/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR21C1033C 2001-05-23 2021-07-27 DRUG DELIVERY SYSTEM COMPRISING TETRAHYDROXYL ESTROGEN FOR HORMONAL CONTRACEPTION Active FR21C1033I2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP01201947 2001-05-23
EP01201946 2001-05-23
EP01201945A EP1293210B1 (en) 2001-05-23 2001-05-23 Means and method for hormonal contraception
EP01204377 2001-11-15
EP02075695 2002-02-21
EP02738961A EP1390042B1 (en) 2001-05-23 2002-05-23 Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
PCT/NL2002/000331 WO2002094279A1 (en) 2001-05-23 2002-05-23 Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception

Publications (2)

Publication Number Publication Date
FR21C1033I1 true FR21C1033I1 (en) 2021-10-15
FR21C1033I2 FR21C1033I2 (en) 2022-04-22

Family

ID=27513107

Family Applications (1)

Application Number Title Priority Date Filing Date
FR21C1033C Active FR21C1033I2 (en) 2001-05-23 2021-07-27 DRUG DELIVERY SYSTEM COMPRISING TETRAHYDROXYL ESTROGEN FOR HORMONAL CONTRACEPTION

Country Status (12)

Country Link
US (1) US7732430B2 (en)
EP (1) EP1390042B1 (en)
CA (1) CA2448278C (en)
CY (2) CY1108093T1 (en)
DE (1) DE60223795T2 (en)
DK (1) DK1390042T3 (en)
ES (1) ES2296943T3 (en)
FR (1) FR21C1033I2 (en)
LU (1) LUC00213I2 (en)
NL (1) NL301115I2 (en)
PT (1) PT1390042E (en)
WO (1) WO2002094279A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1556058T3 (en) 2002-10-23 2008-03-03 Pantarhei Bioscience Bv Pharmaceutical compositions comprising oestetrol derivatives for use in cancer therapy
SI1562976T1 (en) 2002-11-08 2010-08-31 Pantarhei Bioscience Bv Synthesis of estetrol via estrone derived steroids
PT2714712T (en) 2011-06-01 2016-11-08 Estetra Sprl Process for the production of estetrol intermediates
WO2012164096A1 (en) 2011-06-01 2012-12-06 Estetra S.A. Process for the production of estetrol intermediates
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
HUE025350T2 (en) 2011-07-19 2016-02-29 Pantarhei Bioscience Bv Tablet containing dehydroepiandrosterone (dhea)
US9579329B2 (en) * 2011-08-11 2017-02-28 Estetra S.P.R.L. Use of estetrol as emergency contraceptive
WO2013034780A2 (en) 2012-12-20 2013-03-14 Crystal Pharma, S.A.U. Process for the preparation of estetrol and related compounds
WO2015040051A1 (en) 2013-09-18 2015-03-26 Crystal Pharma, S.A.U. Process for the preparation of estetrol
MA39105B1 (en) 2013-12-12 2018-05-31 Donesta Bioscience B V Orally disintegrating solid dosage unit containing a constituent estetrol
MX2017016276A (en) 2015-06-18 2018-06-19 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component.
LT3310346T (en) 2015-06-18 2021-06-10 Estetra Sprl Orodispersible tablet containing estetrol
MA44205B1 (en) 2015-06-18 2021-04-30 Estetra Sprl Orodispersible tablet comprising estetrol
TN2017000497A1 (en) 2015-06-18 2019-04-12 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component
KR20220144885A (en) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 Method for the management of dysmenorrhea and menstrual pain
JOP20200169A1 (en) * 2018-02-07 2020-07-07 Estetra Sprl Contraceptive composition with reduced cardiovascular effects
JOP20200260A1 (en) 2018-04-19 2019-10-19 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
TWI801561B (en) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 Compounds and their uses for alleviating menopause-associated symptoms
HU231240B1 (en) 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Industrial process for the preparation of high-purity estetrol
WO2023152682A1 (en) 2022-02-10 2023-08-17 Estetra Srl Contraceptive methods with scheduled bleeding effects

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3440320A (en) 1964-06-18 1969-04-22 Mortimer D Sackler Chelated suppository and method of using same
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
DE2336433A1 (en) 1973-07-13 1975-04-03 Schering Ag 1,3-disubstd. 8 alpha oestratrienes - oestrogens with minimal uterotropic activity
DE2426779A1 (en) 1974-05-31 1975-12-18 Schering Ag 1,3-disubstd. 8 alpha oestratrienes - oestrogens with minimal uterotropic activity
DE2336434A1 (en) 1973-07-13 1975-04-17 Schering Ag 1,3-disubstd. 8 alpha oestratrienes - oestrogens with minimal uterotropic activity
US4722941A (en) 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
US4460372A (en) 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4573996A (en) 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4624665A (en) 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4937238A (en) 1986-03-04 1990-06-26 The Board Of Regents Of The University Of Nebraska Prevention of mammary carcinoma
US4762717A (en) 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US5223261A (en) 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
US5043331A (en) 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
US5130137A (en) 1989-08-09 1992-07-14 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
JPH04235171A (en) 1990-07-26 1992-08-24 Sumitomo Chem Co Ltd Sulfohydroxamic acid derivative, production thereof and herbicide containing the same derivative as active ingredient
US5063507A (en) 1990-09-14 1991-11-05 Plains Cotton Cooperative Association Goods database employing electronic title or documentary-type title
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5340586A (en) 1991-04-12 1994-08-23 University Of Southern California Methods and formulations for use in treating oophorectomized women
US5340585A (en) 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
US5468736A (en) 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
US5895783A (en) 1993-07-16 1999-04-20 Schering Aktiengesellschaft Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
NL9301562A (en) 1993-09-09 1995-04-03 Saturnus Ag Substitution therapy preparation.
DE4344405C2 (en) 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Anti-ovulation agent and method for hormonal contraception
WO1996003929A1 (en) 1994-08-04 1996-02-15 Biex, Inc. Method for prediction of premature delivery using estetrol (e4) as an indicator
DE4429374C1 (en) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmaceutical preparations for contraception / hormone substitution with biogenic estrogen component
DE69831241T2 (en) 1997-06-20 2006-03-23 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
DE19739916C2 (en) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
DE19917930A1 (en) 1999-04-15 2000-10-19 Schering Ag Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity
EP1171091A1 (en) 1999-04-16 2002-01-16 Jenapharm GmbH & Co. KG Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones
AU5137900A (en) 1999-05-28 2000-12-18 University Of Cincinnati, The Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
WO2001030356A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Hormonal composition based on a progestational agent and an oestrogen and use thereof
AU2001259847B9 (en) 2000-05-12 2006-08-10 Oregon Health And Science University Method of treating immune pathologies with low dose estrogen
US6936599B2 (en) 2001-04-25 2005-08-30 The Regents Of The University Of California Estriol therapy for multiple sclerosis and other autoimmune diseases
EP1260225A1 (en) 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
EP1446128B1 (en) * 2001-11-15 2006-12-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy

Also Published As

Publication number Publication date
US20040198710A1 (en) 2004-10-07
DE60223795T2 (en) 2008-11-27
EP1390042B1 (en) 2007-11-28
DE60223795D1 (en) 2008-01-10
DK1390042T3 (en) 2008-03-31
NL301115I1 (en) 2021-07-14
NL301115I2 (en) 2021-10-25
US7732430B2 (en) 2010-06-08
EP1390042A1 (en) 2004-02-25
CY1108093T1 (en) 2014-02-12
ES2296943T3 (en) 2008-05-01
PT1390042E (en) 2008-03-10
FR21C1033I2 (en) 2022-04-22
LUC00213I1 (en) 2021-07-08
CA2448278C (en) 2010-06-08
CY2021020I1 (en) 2021-12-31
WO2002094279A1 (en) 2002-11-28
CA2448278A1 (en) 2002-11-28
CY2021020I2 (en) 2021-12-31
LUC00213I2 (en) 2021-10-29

Similar Documents

Publication Publication Date Title
FR21C1033I2 (en) DRUG DELIVERY SYSTEM COMPRISING TETRAHYDROXYL ESTROGEN FOR HORMONAL CONTRACEPTION
FR2792842B1 (en) DRUG BOLUS DELIVERY SYSTEM
EP1091732A4 (en) Effervescent drug delivery system for oral administration
EP1416920A4 (en) Multiplex drug delivery system suitable for oral administration
HUP0001914A3 (en) Biocompatible compounds for pharmaceutical drug delivery systems
EP1150629A4 (en) Drug dosage unit for buccal administration of steroidal active agents
HUP0401438A3 (en) Drug delivery system
IL157771A (en) Intravaginal drug delivery devices for the administration of an antimicrobial agent
PT1239831E (en) Improved pharmaceutical compositions for poorly soluble drugs
FR2795967B1 (en) SYSTEM FOR PROTECTING AN IMPLANTABLE MEDICATION DELIVERY DEVICE AGAINST EXCESSIVE FILLING
GB0111762D0 (en) Drug delivery mask for animals
HK1048428A1 (en) Ophthalmic drug delivery device.
HUP0401281A3 (en) Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals
HK1048427A1 (en) Drug delivery device.
NO20004196D0 (en) Drug delivery devices
HK1077523A1 (en) Proliposomal drug delivery system
AU3787501A (en) New self emulsifying drug delivery system
IL151909A0 (en) Peptide conjugates for drug delivery
HRPK20010706B1 (en) Tolperison-containing, pharmaceutical preparation for oral administration
EE05415B1 (en) Drug delivery device, in particular for the administration of androgens
FR2796287B1 (en) DRUG DELIVERY DEVICE
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
HK1043944A1 (en) A novel drug delivery system: formulation for fat-soluble drugs.
EP1438087A4 (en) System for administering a drug delivery device
AU2002311676A1 (en) Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception